KalVista Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2015 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
KalVista Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2015 to Q3 2024.
  • KalVista Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 26, 2024 was 43.2M shares, a 25.6% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 43.2M +8.81M +25.6% Aug 26, 2024 10-Q 2024-09-05
Q2 2024 42.7M +8.5M +24.8% Jun 25, 2024 10-K 2024-07-11
Q1 2024 42.2M +8.02M +23.5% Feb 29, 2024 10-Q 2024-03-11
Q4 2023 34.6M +9.94M +40.4% Nov 30, 2023 10-Q 2023-12-07
Q3 2023 34.4M +9.8M +39.8% Aug 31, 2023 10-Q 2023-09-07
Q2 2023 34.2M +9.66M +39.3% Jun 28, 2023 10-K 2023-07-10
Q1 2023 34.2M +9.63M +39.2% Mar 1, 2023 10-Q 2023-03-09
Q4 2022 24.6M +148K +0.61% Dec 1, 2022 10-Q 2022-12-08
Q3 2022 24.6M +164K +0.67% Sep 1, 2022 10-Q 2022-09-08
Q2 2022 24.6M +134K +0.55% Jul 2, 2022 10-K 2022-07-07
Q1 2022 24.5M +235K +0.97% Mar 8, 2022 10-Q 2022-03-10
Q4 2021 24.5M +6.53M +36.4% Dec 7, 2021 10-Q 2021-12-09
Q3 2021 24.4M +6.53M +36.5% Sep 7, 2021 10-Q 2021-09-09
Q2 2021 24.4M +6.59M +36.9% Jul 2, 2021 10-K 2021-07-13
Q1 2021 24.3M +6.46M +36.2% Mar 4, 2021 10-Q 2021-03-11
Q4 2020 17.9M +108K +0.61% Dec 3, 2020 10-Q 2020-12-10
Q3 2020 17.9M +92.1K +0.52% Sep 4, 2020 10-Q 2020-09-14
Q2 2020 17.8M +459K +2.64% Jun 24, 2020 10-K 2020-07-01
Q1 2020 17.8M +598K +3.47% Mar 2, 2020 10-Q 2020-03-10
Q4 2019 17.8M +608K +3.53% Nov 30, 2019 10-Q 2019-12-03
Q3 2019 17.8M +636K +3.7% Aug 30, 2019 10-Q 2019-09-09
Q2 2019 17.4M +6.59M +61% Jul 1, 2019 10-K 2019-07-16
Q1 2019 17.2M +6.45M +59.8% Mar 10, 2019 10-Q 2019-03-14
Q4 2018 17.2M +6.44M +59.7% Dec 10, 2018 10-Q 2018-12-14
Q3 2018 17.2M +7.47M +76.9% Sep 10, 2018 10-Q 2018-09-14
Q2 2018 10.8M +1.09M +11.2% Jul 16, 2018 10-K 2018-07-30
Q1 2018 10.8M +1.08M +11.1% Mar 1, 2018 10-Q 2018-03-16
Q4 2017 10.8M Nov 30, 2017 10-Q 2017-12-14
Q3 2017 9.71M -16.6M -63.1% Aug 31, 2017 10-Q 2017-09-14
Q2 2017 9.71M -16.6M -63.1% Jul 1, 2017 10-K 2017-07-27
Q1 2017 9.71M -16.6M -63.1% Feb 28, 2017 10-Q 2017-03-16
Q3 2016 26.3M +21.6K +0.08% Oct 31, 2016 10-Q 2016-11-08
Q2 2016 26.3M +13.3K +0.05% Jul 29, 2016 10-Q 2016-08-12
Q1 2016 26.3M +118K +0.45% Mar 15, 2016 10-K 2016-03-30
Q3 2015 26.3M Oct 31, 2015 10-Q 2015-11-12
Q2 2015 26.3M Jul 31, 2015 10-Q 2015-08-13
Q1 2015 26.2M Apr 30, 2015 10-Q 2015-05-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.